May 18, 2010
Justice Department Targets Fraud Claims
The Justice Department continues its streak of huge recoveries against the pharmaceutical industry.
Thomas P. O'Brien
Partner
Paul Hastings LLP
Thomas is a litigation partner with Paul Hastings in Los Angeles. Prior to joining Paul Hastings, he served as the U.S. attorney for the Central District of California.
Adam D. Schneir
Enforcement Attorney
US Securities & Exchange Commission
John J. O'Kane IV
Skiermont Derby LLPEmail: okane@skiermontderby.com
Johnny represents entity and individual clients through all phases of trial and appeal.
The Justice Department is on a roll. In the past several weeks, it settled whistleblower suits under the False Claims Act (FCA) against pharmaceutical companies for nearly $150 million. During that same period, the Department of Justice also settled a qui tam action involving a private lender for more than $25 million, and intervened in a separate FCA whistleblower suit in Texas.
Since January 2009, the Department of Justice's total recoveries have topped $3 billion in FCA ...For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In